Deletions of multidrug resistance gene loci in breast cancer leads to the down-regulation of its expression and predict tumor response to neoadjuvant chemotherapy

Neoadjuvant chemotherapy (NAC) is intensively used for the treatment of primary breast cancer. In our previous studies, we reported that clinical tumor response to NAC is associated with the change of multidrug resistance (MDR) gene expression in tumors after chemotherapy. In this study we performed...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Litviakov, Nikolai V., Cherdyntseva, Nadezhda V., Tsyganov, Matvey M., Slonimskaya, Elena M., Ibragimova, Marina K., Kazantseva, Polina V., Kzhyshkowska, Julia, Choinzonov, Eugeniy L.
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2016
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4884957/
https://ncbi.nlm.nih.gov/pubmed/26799285
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.6953
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados